Ascletis Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1672?
Owner TypeNumber of SharesOwnership Percentage
Institutions12,336,0001.26%
General Public132,606,26313.6%
Private Companies209,672,01321.5%
Individual Insiders622,167,72463.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 86.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
52.8%
Jinzi Jason Wu
515,549,164HK$855.8m0%no data
10.8%
Yang Dan
105,463,060HK$175.1m0%no data
8.48%
Lakemont Holding Llc
82,827,414HK$137.5m0%no data
6.42%
Jjw11 Limited
62,689,872HK$104.1m0%no data
5.19%
CBC Investment Twelve Limited
50,729,518HK$84.2m0%no data
1.37%
CBC Investment Fifteen Limited
13,425,209HK$22.3m0%no data
0.34%
E Fund Management Co., Ltd.
3,285,000HK$5.5m0%no data
0.28%
Dimensional Fund Advisors LP
2,691,000HK$4.5m-28.8%no data
0.23%
JP Morgan Asset Management
2,265,000HK$3.8m0%no data
0.19%
China Universal Asset Management Company Ltd.
1,818,000HK$3.0m0%no data
0.16%
Fullgoal Fund Management Co. Ltd.
1,591,000HK$2.6m0%no data
0.12%
Hejingdao Wu
1,155,500HK$1.9m0%no data
0.051%
China Southern Asset Management Co., Ltd.
500,000HK$830.0k0%no data
0.019%
American Century Investment Management Inc
186,000HK$308.7k0%no data